People In The News: EFPIA Seeks New Leader, Medicines Australia Finds One
Executive Summary
EFPIA's Richard Bergström is moving on; Medicines Australia brings in UK-based lobbyist Milton Catelin as its CEO; Friends of Cancer Research promotes Jeff Allen to CEO, plus more biopharma personnel changes.
You may also be interested in...
O’Neill Optimistic Global AMR Review Won’t Lose Steam
Jim O'Neill says he spends sleepless nights worrying whether his Review of Antimicrobial Resistance (AMR) will run out of steam once completed in two months' time - but he's encouraged by growing evidence world leaders and the pharma industry are seriously embracing the theme and will soon make lasting commitments to effectively combat antibiotic resistance, including in Asia.
Medicines Australia CEO Resigns After "Challenging" Year
Tim James has resigned as CEO of the pharmaceutical industry body Medicines Australia, effective from January 20161. The search for a successor will begin next year.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.